Corrigendum: The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales

McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2017) Corrigendum: The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. Rheumatology, 56 (6). p. 1049. ISSN 1462-0324

Metadata

Item Type: Article
Authors/Creators:
  • McCarthy, EM
  • Sutton, E
  • Nesbit, S
  • Parker, B
  • Jayne, D
  • Griffiths, B
  • Isenberg, DA
  • Rahman, A
  • Gordon, C
  • D’Cruz, DP
  • Rhodes, B
  • Lanyon, P
  • Vital, EM ORCID logo https://orcid.org/0000-0003-1637-4755
  • Yee, C-S
  • Edwards, CJ
  • Teh, L-S
  • Akil, M
  • McHugh, NJ
  • Zoma, A
  • Bruce, IN
  • British Isles Lupus Assessment Group Biologics Register
Commentary on: McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2017) The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. Rheumatology, 56 (6). pp. 1041-1043. ISSN 1462-0324
Dates:
  • Published: 1 June 2017
  • Published (online): 22 May 2017
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 25 Sep 2018 14:53
Last Modified: 25 Sep 2018 15:04
Status: Published
Publisher: Oxford University Press
Identification Number: 10.1093/rheumatology/kex218
Open Archives Initiative ID (OAI ID):

Commentary/Response Threads

Export

Statistics